This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.
References
(1). Clarke CE. Parkinson's disease. British Medical Journal 2007; 335;
441-445
(2). Arnulf I, Leu-Semenescu S. Sleepiness in Parkinson's disease.
Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S101-4.
(3). Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome.
Lancet Neurol 2005; 4: 465.
(4). Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and
coping in quality of life in fibromyalgia. J Psychosom Res. 2007;
62(2):145-51.
(5). Bazil CW. Comprehensive care of the epilepsy patient--control,
comorbidity, and cost. Epilepsia. 2004;45 Suppl 6:3-12.
(6). Hermann DM, Bassetti CL. Sleep-related breathing and sleep-wake
disturbances in ischemic stroke Neurology. 2009; 73:1313-22.
(7). Cvetkovic-Lopes V, Bayer L, Dorsaz S et al. Elevated Tribbles
homolog 2-specific antibody levels in narcolepsy patients. J Clin
Invest. 2010 Feb 15. pii: 41366. doi: 10.1172/JCI41366. 2010 March;
120 (3); 713-719.
(8). http://www.friglobalevents.com/wasmonlin... - [accessed 3rd March
2010]
(9). http://www.ninds.nih.gov/ - [accessed 3rd March 2010]
For further information: Eimear O Brien, CNS Communications, UCB T +32-559-9271, eimear.obrien@ucb.com; Nancy Nackaerts, External Communications, UCB T +32-473-864-414, nancy.nackaerts@ucb.com
